KRAS and endometrial carcinoma: In addition, a mutual exclusion between RASSF1A inactivation by methylation and K-Ras mutation was observed in a number of human cancers such as pancreatic cancer and endometrial carcinoma[36,37], supporting the association of RASSF1A with the Ras signaling pathways.